Table 3

Clinical and echocardiographic characteristics of patients with hypertrophic cardiomyopathy carrying sarcomeric and rare variants (MAF≤ 0.5% in control population) in GATA genes

GATA geneNumber of carriersPositionNucleotide variantAmino acid changeSarcomeric geneNumber of carriersdbSNP IDPositionAmino acid changeSex/ageIVSClinical profile
21E1c.-77G>AMYH71E16p.Ala583ValM/3823Dyspnea (class III–IV), angina, syncope, palpitations
1E6c.*508G>AMYH71rs767300277E39p.Ile1927PheF/5216Angina
41E2c.-306C>TMYH71rs201307101E32p.Lys1459AsnF/5619Dyspnea (class III–IV), angina, arrhythmia, murmur, palpitations
1E3c.699G>Ap.Thr233=MYBPC31rs121909374E18p.Glu542GlnM/5720Angina, murmur
1E6c.1056C>Tp.Asn352=TNNT21rs397516470E11p.Glu163delF/3528Dyspnea (class I–II), palpitations
61E1c.-181G>ATNNT21rs121964856E9p.Arg92GlnF/–17Palpitations
1E2c.851C>Gp.Ala284GlyACTC1
MYH7
1
1
rs193922680
rs371898076
E3
E18
p. Glu101Lys
p.Arg663His
F/25
F/51
17
29
Asymptomatic
Dyspnea (class I–II), angina, murmur
2E7c.1663C>Gp.Pro555AlaMYBPC31E7p.Gly263delM/4917Asymptomatic
  • dbSNP ID, single-nucleotide polymorphism identification in the database dbSNP; E, exon; F, female; IVS, interventricular septum thickness (mm); M, male.

  • Class refers to New York Heart Association functional class. Positions of variants based on GATA2 RefSeq NM_032638.4, NP_116027.2; GATA4 RefSeq NM_002052.3, NP_002043.2; GATA6 RefSeq NM_005257.3, NP_005248.2; MYH7 RefSeq NP_000248.2; MYBPC3 RefSeq NP_000247.2; TNNT2 RefSeq NP_001263276.1; ACTC1 RefSeq NP_005150.1.